Contract facts
FederalMONITORING THE CONDUCT AND PROGRESS OF EXTRAMURAL FDA-FUNDED CDER RESEARCH IN HUMAN SUBJECTS is a federal award for Fda Office Of Acq Grant Svcs held by Realm Research LLC. Estimated value $66.3M ($66.3M obligated). Current period of performance ends Jun 27, 2029 (potential Sep 29, 2029). Place of performance: POWDER SPRINGS, GA. Related solicitation 75F40124R00027.
MONITORING THE CONDUCT AND PROGRESS OF EXTRAMURAL FDA-FUNDED CDER RESEARCH IN HUMAN SUBJECTS
Recompete timing
PublicCurrent PoP ends Jun 27, 2029 (1042 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Dec 27, 2027.
Incumbent footprint
Public recordRealm Research LLC — $184K obligated across 4 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40124F19002?
75F40124F19002 (Monitoring the conduct and progress of) is a Fda Office Of Acq Grant Svcs award with an estimated value of $66.3M, currently held by Realm Research LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40124F19002?
Fda Office Of Acq Grant Svcs awarded 75F40124F19002 to Realm Research LLC.
Who is the incumbent on 75F40124F19002?
Realm Research LLC is the incumbent with $184K across 4 related awards in SCOUT’s public footprint. The current period of performance ends Jun 27, 2029.
When does Realm Research LLC’s 75F40124F19002 come up for recompete?
SCOUT tracks a period-of-performance end of Jun 27, 2029. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.